PR90718

SHENZHEN, China, July 19, 2021 /PRNewswire=KYODO JBN/ --

On June 17th, the Shenzhou-12 spacecraft consisting of a crew of three was

launched into space, taking one step forward to establish China's Tiangong

space station which is under construction in a Low-Earth orbit. Astronauts will

stay in space for three months to conduct extravehicular activities and the

in-orbit verifications of major technologies.

Prolonged exposure to microgravity causes multiple physiological and

biochemical changes in humans, including cardiovascular deconditioning that

leads to orthostatic intolerance, musculoskeletal complaints, urinary tract

infections and etc. Currently, ultrasound is still the modality of choice for

the diagnosis and treatment of medical contingencies in space[1].

In this mission, astronauts conducted ultrasound examinations during

spaceflight to monitor their health condition. SonoScape's X5 was honored to be

selected by China National Space Administration (CNAS) to support medical

research in the aviation environment. It becomes the first Chinese ultrasound

system that is going to function in orbit to help assess the impact of

long-duration microgravity space flight on astronauts.

"Ensuring the usability and stability, our ultrasound system passed the

rigorous regimen of hardware qualification and acceptance testing," said Dr.

Feng, General Manager of Ultrasound Division at SonoScape. "Our R&D team pushed

the boundaries enabling space imaging to reach a high level; Aerospace

ultrasound examination will give researchers a deeper insight of long-term zero

gravity and radiation on human's body."

According to China Manned Space Program, the construction of the space station

will be completed by 2022, supporting the long stay of astronauts and

large-scale scientific, technological, and application experiments. SonoScape

will continuously undertake the mission of assisting aerospace medical research

and providing effective information that leads to the improvement of the crew

members' health care.

Reference:

1.Law J, Macbeth PB. Ultrasound:from Earth to space.Mcgill J

Med.2011:13(2):59                                                              

About SonoScape

Founded in 2002 in Shenzhen, China, SonoScape has committed itself to "Caring

for life through innovation" by providing ultrasound and endoscopy solutions

and delivering first-rate services. It now has seven R&D centers in Shenzhen,

Shanghai, Harbin, Wuhan, Tokyo, Silicon Valley and Seattle. SonoScape invests

nearly 20% of its revenues into R&D in recent 3 years, with more advanced

products to be introduced into the pipeline.

Source: SonoScape Medical Corporation